Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

Clinical significance of Pseudomonas aeruginosa 2-alkyl-4-quinolone quorum-sensing signal molecules for long-term outcomes in adults with cystic fibrosis.

Webb K, Fogarty A, Barrett DA, Nash EF, Whitehouse JL, Smyth AR, Stewart I, Knox A, Williams P, Halliday N, Cámara M, Barr HL.

J Med Microbiol. 2019 Oct 31. doi: 10.1099/jmm.0.001099. [Epub ahead of print]

PMID:
31671047
2.

Implementation fidelity of village health and nutrition days in Hardoi District, Uttar Pradesh, India: a cross-sectional survey.

Johri M, Rodgers L, Chandra D, Abou-Rizk C, Nash E, Mathur AK.

BMC Health Serv Res. 2019 Oct 26;19(1):756. doi: 10.1186/s12913-019-4625-9.

3.

The Swansea 6D model: a diagnostic and conversational framework for supervisors, mentors and doctors in training.

McKimm J, Vogan CL, Roberts C, Nash E, Hothersall E, Jones PK.

Postgrad Med J. 2019 Sep;95(1127):482-486. doi: 10.1136/postgradmedj-2018-136258. Epub 2019 Jul 11.

PMID:
31296793
4.

Evaluation of absorption, distribution, metabolism, and excretion of [14C]-rucaparib, a poly(ADP-ribose) polymerase inhibitor, in patients with advanced solid tumors.

Liao M, Watkins S, Nash E, Isaacson J, Etter J, Beltman J, Fan R, Shen L, Mutlib A, Kemeny V, Pápai Z, van Tilburg P, Xiao JJ.

Invest New Drugs. 2019 Jun 27. doi: 10.1007/s10637-019-00815-2. [Epub ahead of print]

PMID:
31250355
5.

Abortion Rights in Peril - What Clinicians Need to Know.

Nash E.

N Engl J Med. 2019 Aug 8;381(6):497-499. doi: 10.1056/NEJMp1906972. Epub 2019 Jun 19. No abstract available.

PMID:
31216418
6.

Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis.

Huang M, Tailor J, Zhen Q, Gillmor AH, Miller ML, Weishaupt H, Chen J, Zheng T, Nash EK, McHenry LK, An Z, Ye F, Takashima Y, Clarke J, Ayetey H, Cavalli FMG, Luu B, Moriarity BS, Ilkhanizadeh S, Chavez L, Yu C, Kurian KM, Magnaldo T, Sevenet N, Koch P, Pollard SM, Dirks P, Snyder MP, Largaespada DA, Cho YJ, Phillips JJ, Swartling FJ, Morrissy AS, Kool M, Pfister SM, Taylor MD, Smith A, Weiss WA.

Cell Stem Cell. 2019 Sep 5;25(3):433-446.e7. doi: 10.1016/j.stem.2019.05.013. Epub 2019 Jun 13.

7.

Patients attending an emergency department with a general practitioner referral letter who are discharged home have a longer length of stay than those without a letter.

Parsonage MT, Nash E, Chalkley D, Hespe C.

Emerg Med Australas. 2019 Jun;31(3):495-496. doi: 10.1111/1742-6723.13284. Epub 2019 Mar 18. No abstract available.

PMID:
30883008
8.

The response of Escherichia coli to the alkylating agents chloroacetaldehyde and styrene oxide.

Muenter MM, Aiken A, Akanji JO, Baig S, Bellou S, Carlson A, Conway C, Cowell CM, DeLateur NA, Hester A, Joshi C, Kramer C, Leifer BS, Nash E, Qi MH, Travers M, Wong KC, Hu M, Gou N, Giese RW, Gu AZ, Beuning PJ.

Mutat Res Genet Toxicol Environ Mutagen. 2019 Apr;840:1-10. doi: 10.1016/j.mrgentox.2019.02.001. Epub 2019 Feb 7.

PMID:
30857727
9.

Binding characterization of N-(2-chloro-5-thiomethylphenyl)-N'-(3-[3 H]3 methoxy phenyl)-N'-methylguanidine ([3 H]GMOM), a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist.

Metaxas A, van Berckel BNM, Klein PJ, Verbeek J, Nash EC, Kooijman EJM, Renjaän VA, Golla SSV, Boellaard R, Christiaans JAM, Windhorst AD, Leysen JE.

Pharmacol Res Perspect. 2019 Feb;7(1):e00458. doi: 10.1002/prp2.458.

10.

Platelet decoys inhibit thrombosis and prevent metastatic tumor formation in preclinical models.

Papa AL, Jiang A, Korin N, Chen MB, Langan ET, Waterhouse A, Nash E, Caroff J, Graveline A, Vernet A, Mammoto A, Mammoto T, Jain A, Kamm RD, Gounis MJ, Ingber DE.

Sci Transl Med. 2019 Feb 13;11(479). pii: eaau5898. doi: 10.1126/scitranslmed.aau5898.

PMID:
30760580
11.

In vitro activity of EDTA and TOL-463 against Neisseria gonorrhoeae.

Nash EE, Henning TC, Pham CD, Pettus K, Sharpe S, Kersh EN.

Diagn Microbiol Infect Dis. 2019 Apr;93(4):369-371. doi: 10.1016/j.diagmicrobio.2018.10.021. Epub 2018 Nov 10.

PMID:
30552033
12.

Evaluation of Drug-Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp Substrates in Patients With an Advanced Solid Tumor.

Xiao JJ, Nowak D, Ramlau R, Tomaszewska-Kiecana M, Wysocki PJ, Isaacson J, Beltman J, Nash E, Kaczanowski R, Arold G, Watkins S.

Clin Transl Sci. 2019 Jan;12(1):58-65. doi: 10.1111/cts.12600. Epub 2018 Dec 20.

13.

Pragmatic criteria to define chronic pseudomonas aeruginosa infection among adults with cystic fibrosis.

Hoo ZH, Coates E, Maguire C, Cantrill H, Shafi N, Nash EF, McGowan A, Bourke SJ, Flight WG, Daniels TV, Nightingale JA, Allenby MI, Curley R, Wildman MJ.

Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2219-2222. doi: 10.1007/s10096-018-3358-8. Epub 2018 Aug 18. No abstract available.

PMID:
30121804
14.

Infectious Disease in Contact Sports.

Peterson AR, Nash E, Anderson BJ.

Sports Health. 2019 Jan/Feb;11(1):47-58. doi: 10.1177/1941738118789954. Epub 2018 Aug 14. Review.

15.

Stump Appendicitis.

Essenmacher AC, Nash E, Walker SK, Pitcher GJ, Buresh CT, Sato TS.

Clin Pract Cases Emerg Med. 2018 May 18;2(3):211-214. doi: 10.5811/cpcem.2018.3.37730. eCollection 2018 Aug.

16.

Immune Protection against Lethal Fungal-Bacterial Intra-Abdominal Infections.

Lilly EA, Ikeh M, Nash EE, Fidel PL Jr, Noverr MC.

MBio. 2018 Jan 16;9(1). pii: e01472-17. doi: 10.1128/mBio.01472-17.

17.

Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study; response to comments.

Barr HL, Halliday N, Barrett DA, Williams P, Forrester DL, Peckham D, Williams K, Smyth AR, Honeybourne D, Whitehouse JL, Nash EF, Dewar J, Clayton A, Knox AJ, Cámara M, Fogarty AW.

J Cyst Fibros. 2017 Nov;16(6):e21. doi: 10.1016/j.jcf.2017.09.008. Epub 2017 Oct 25. No abstract available.

18.

Improving the care of patients with cystic fibrosis (CF).

Khan AA, Nash EF, Whitehouse J, Rashid R.

BMJ Open Qual. 2017 Sep 4;6(2):e000020. doi: 10.1136/bmjoq-2017-000020. eCollection 2017.

19.

Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis.

Barr HL, Cámara M, Barrett D, Williams P, Forrester D, Smyth A, Honeybourne D, Whitehouse J, Nash E, Dewar J, Knox A, Fogarty AW.

ERJ Open Res. 2017 Aug 25;3(3). pii: 00057-2017. doi: 10.1183/23120541.00057-2017. eCollection 2017 Jul.

20.

The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers.

Rowbotham NJ, Smith S, Leighton PA, Rayner OC, Gathercole K, Elliott ZC, Nash EF, Daniels T, Duff AJA, Collins S, Chandran S, Peaple U, Hurley MN, Brownlee K, Smyth AR.

Thorax. 2018 Apr;73(4):388-390. doi: 10.1136/thoraxjnl-2017-210473. Epub 2017 Aug 4.

21.

Facebook advertising for participant recruitment into a blood pressure clinical trial.

Nash EL, Gilroy D, Srikusalanukul W, Abhayaratna WP, Stanton T, Mitchell G, Stowasser M, Sharman JE.

J Hypertens. 2017 Dec;35(12):2527-2531. doi: 10.1097/HJH.0000000000001477.

PMID:
28704263
22.

Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.

Greenwood J, Schwarz C, Sommerwerck U, Nash EF, Tamm M, Cao W, Mastoridis P, Debonnett L, Hamed K.

Ther Adv Respir Dis. 2017 Jul;11(7):249-260. doi: 10.1177/1753465817710596.

23.

Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA.

Papp JR, Abrams AJ, Nash E, Katz AR, Kirkcaldy RD, O'Connor NP, O'Brien PS, Harauchi DH, Maningas EV, Soge OO, Kersh EN, Komeya A, Tomas JE, Wasserman GM, Kunimoto GY, Trees DL, Whelen AC.

Emerg Infect Dis. 2017 May;23(5):830-832. doi: 10.3201/eid2305.170088.

24.

A prospective pilot study of home monitoring in adults with cystic fibrosis (HOME-CF): protocol for a randomised controlled trial.

Choyce J, Shaw KL, Sitch AJ, Mistry H, Whitehouse JL, Nash EF.

BMC Pulm Med. 2017 Jan 23;17(1):22. doi: 10.1186/s12890-017-0366-x.

25.

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.

Bryant JM, Grogono DM, Rodriguez-Rincon D, Everall I, Brown KP, Moreno P, Verma D, Hill E, Drijkoningen J, Gilligan P, Esther CR, Noone PG, Giddings O, Bell SC, Thomson R, Wainwright CE, Coulter C, Pandey S, Wood ME, Stockwell RE, Ramsay KA, Sherrard LJ, Kidd TJ, Jabbour N, Johnson GR, Knibbs LD, Morawska L, Sly PD, Jones A, Bilton D, Laurenson I, Ruddy M, Bourke S, Bowler IC, Chapman SJ, Clayton A, Cullen M, Daniels T, Dempsey O, Denton M, Desai M, Drew RJ, Edenborough F, Evans J, Folb J, Humphrey H, Isalska B, Jensen-Fangel S, Jönsson B, Jones AM, Katzenstein TL, Lillebaek T, MacGregor G, Mayell S, Millar M, Modha D, Nash EF, O'Brien C, O'Brien D, Ohri C, Pao CS, Peckham D, Perrin F, Perry A, Pressler T, Prtak L, Qvist T, Robb A, Rodgers H, Schaffer K, Shafi N, van Ingen J, Walshaw M, Watson D, West N, Whitehouse J, Haworth CS, Harris SR, Ordway D, Parkhill J, Floto RA.

Science. 2016 Nov 11;354(6313):751-757. doi: 10.1126/science.aaf8156.

26.

Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study.

Barr HL, Halliday N, Barrett DA, Williams P, Forrester DL, Peckham D, Williams K, Smyth AR, Honeybourne D, L Whitehouse J, Nash EF, Dewar J, Clayton A, Knox AJ, Cámara M, Fogarty AW.

J Cyst Fibros. 2017 Mar;16(2):230-238. doi: 10.1016/j.jcf.2016.10.005. Epub 2016 Oct 20.

27.

Chest wall motion analysis in healthy volunteers and adults with cystic fibrosis using a novel Kinect-based motion tracking system.

Harte JM, Golby CK, Acosta J, Nash EF, Kiraci E, Williams MA, Arvanitis TN, Naidu B.

Med Biol Eng Comput. 2016 Nov;54(11):1631-1640. Epub 2016 Feb 13.

28.

'Cathy became my confidante'.

Nash E.

Nurs Stand. 2016 Jun 29;30(44):65. doi: 10.7748/ns.30.44.65.s48.

PMID:
27353939
29.

A retrospective audit of referral letter quality from general practice to an inner-city emergency department.

Nash E, Hespe C, Chalkley D.

Emerg Med Australas. 2016 Jun;28(3):313-8. doi: 10.1111/1742-6723.12592. Epub 2016 May 20.

PMID:
27197892
30.

Peer-to-Peer Feedback: A Novel Approach to Nursing Quality, Collaboration, and Peer Review.

LeClair-Smith C, Branum B, Bryant L, Cornell B, Martinez H, Nash E, Phillips L.

J Nurs Adm. 2016 Jun;46(6):321-8. doi: 10.1097/NNA.0000000000000352.

PMID:
27163874
31.

Short-term and long-term cardiovascular risk, metabolic syndrome and HIV in Tanzania.

Kingery JR, Alfred Y, Smart LR, Nash E, Todd J, Naguib MR, Downs JA, Kalluvya S, Kataraihya JB, Peck RN.

Heart. 2016 Aug 1;102(15):1200-5. doi: 10.1136/heartjnl-2015-309026. Epub 2016 Apr 22.

32.

Never Say Never Again.

Wiesenthal AM, Nash E, Sklar D, Snyder M.

Popul Health Manag. 2016 Oct;19(5):304-5. doi: 10.1089/pop.2016.0006. Epub 2016 Mar 30. No abstract available.

PMID:
27028262
33.

A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response.

Nash EE, Peters BM, Lilly EA, Noverr MC, Fidel PL Jr.

PLoS One. 2016 Jan 25;11(1):e0147969. doi: 10.1371/journal.pone.0147969. eCollection 2016.

34.

Morphology-Independent Virulence of Candida Species during Polymicrobial Intra-abdominal Infections with Staphylococcus aureus.

Nash EE, Peters BM, Fidel PL, Noverr MC.

Infect Immun. 2015 Oct 19;84(1):90-8. doi: 10.1128/IAI.01059-15. Print 2016 Jan.

35.

Abortion Context and Women's Contraceptive Use.

Jones RK, Nash E.

Perspect Sex Reprod Health. 2015 Sep;47(3):157-8. doi: 10.1363/47e4915. No abstract available.

PMID:
26375318
36.

Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis.

Barr HL, Halliday N, Cámara M, Barrett DA, Williams P, Forrester DL, Simms R, Smyth AR, Honeybourne D, Whitehouse JL, Nash EF, Dewar J, Clayton A, Knox AJ, Fogarty AW.

Eur Respir J. 2015 Oct;46(4):1046-54. doi: 10.1183/09031936.00225214. Epub 2015 May 28.

37.

Yellow Fever Vaccination of a Primary Vaccinee During Adalimumab Therapy.

Nash ER, Brand M, Chalkias S.

J Travel Med. 2015 Jul-Aug;22(4):279-81. doi: 10.1111/jtm.12209. Epub 2015 Apr 29.

38.

Primary hyperparathyroidism in pregnancy leading to hypercalcaemic crisis and uraemic encephalopathy.

Nash E, Ranka P, Tarigopula G, Rashid T.

BMJ Case Rep. 2015 Mar 27;2015. pii: bcr2014208829. doi: 10.1136/bcr-2014-208829. Erratum in: BMJ Case Rep. 2015;2015. pii: bcr2014208829corr1. doi: 10.1136/bcr-2014-208829corr1.

39.

Physical activity in adults with cystic fibrosis receiving intravenous antibiotics in hospital and in the community.

Khiroya H, Pound R, Qureshi U, Brown C, Barrett J, Rashid R, Whitehouse JL, Turner AM, Nash EF.

Open Respir Med J. 2015 Feb 25;9:15-21. doi: 10.2174/1874306401509010015. eCollection 2015.

40.

A semi-dominant mutation in the general splicing factor SF3a66 causes anterior-posterior axis reversal in one-cell stage C. elegans embryos.

Keikhaee MR, Nash EB, O'Rourke SM, Bowerman B.

PLoS One. 2014 Sep 4;9(9):e106484. doi: 10.1371/journal.pone.0106484. eCollection 2014.

41.

Morphogenesis is not required for Candida albicans-Staphylococcus aureus intra-abdominal infection-mediated dissemination and lethal sepsis.

Nash EE, Peters BM, Palmer GE, Fidel PL, Noverr MC.

Infect Immun. 2014 Aug;82(8):3426-35. doi: 10.1128/IAI.01746-14. Epub 2014 Jun 2.

42.
43.

Employment in adults with cystic fibrosis.

Targett K, Bourke S, Nash E, Murphy E, Ayres J, Devereux G.

Occup Med (Lond). 2014 Mar;64(2):87-94. doi: 10.1093/occmed/kqt140. Epub 2013 Dec 24.

PMID:
24368524
44.

Abdominal pain in adults with cystic fibrosis.

Nash EF, Ohri CM, Stephenson AL, Durie PR.

Eur J Gastroenterol Hepatol. 2014 Feb;26(2):129-36. doi: 10.1097/MEG.0000000000000011. Review.

PMID:
24366450
45.

Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.

Tam J, Nash EF, Ratjen F, Tullis E, Stephenson A.

Cochrane Database Syst Rev. 2013 Jul 12;(7):CD007168. doi: 10.1002/14651858.CD007168.pub3. Review.

PMID:
23852992
46.

Microbial contamination of non-invasive ventilation devices used by adults with cystic fibrosis.

Mutagi A, Nash EF, Cameron S, Abbott G, Agostini P, Whitehouse JL, Honeybourne D, Boxall E.

J Hosp Infect. 2012 Jun;81(2):104-8. doi: 10.1016/j.jhin.2012.03.004. Epub 2012 May 10.

PMID:
22579442
47.

Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expression.

Philibert RA, Sears RA, Powers LS, Nash E, Bair T, Gerke AK, Hassan I, Thomas CP, Gross TJ, Monick MM.

J Leukoc Biol. 2012 Sep;92(3):621-31. doi: 10.1189/jlb.1211632. Epub 2012 Mar 16.

48.

Implications of the current UK welfare reforms for adults with cystic fibrosis.

Nash EF, Kavanagh D, Williams S, Bikmalla S, Gray A, Whitehouse JL.

Clin Med (Lond). 2011 Dec;11(6):634. No abstract available.

49.

Long-term impact of liver transplantation on respiratory function and nutritional status in children and adults with cystic fibrosis.

Dowman JK, Watson D, Loganathan S, Gunson BK, Hodson J, Mirza DF, Clarke J, Lloyd C, Honeybourne D, Whitehouse JL, Nash EF, Kelly D, van Mourik I, Newsome PN.

Am J Transplant. 2012 Apr;12(4):954-64. doi: 10.1111/j.1600-6143.2011.03904.x. Epub 2012 Jan 6.

50.

Unprecedented Arctic ozone loss in 2011.

Manney GL, Santee ML, Rex M, Livesey NJ, Pitts MC, Veefkind P, Nash ER, Wohltmann I, Lehmann R, Froidevaux L, Poole LR, Schoeberl MR, Haffner DP, Davies J, Dorokhov V, Gernandt H, Johnson B, Kivi R, Kyrö E, Larsen N, Levelt PF, Makshtas A, McElroy CT, Nakajima H, Parrondo MC, Tarasick DW, von der Gathen P, Walker KA, Zinoviev NS.

Nature. 2011 Oct 2;478(7370):469-75. doi: 10.1038/nature10556.

PMID:
21964337

Supplemental Content

Support Center